Antiemetic Therapy Guidelines

Introduction to Antiemetic Therapy

Antiemetic therapy is crucial for managing nausea and vomiting in various settings, including chemotherapy-induced nausea/vomiting, according to the National Comprehensive Cancer Network 1

The National Comprehensive Cancer Network recommends a standard dose of 10 mg every 6 hours as needed, with a maximum daily dose of 40 mg for oral prochlorperazine administration 1, 2, 3
A standard dose of 25 mg suppository every 12 hours is recommended for patients who cannot take oral medications 4
IV prochlorperazine has a standard dose of 5-10 mg, with higher bioavailability and less variability compared to oral administration, according to the Journal of Clinical Oncology and the Mayo Clinic Proceedings 2, 5
For patients requiring rapid control of nausea and vomiting, IV administration at lower doses (2.5-5 mg) provides faster and more reliable relief than oral administration 2

Prochlorperazine is effective for nausea and vomiting in various settings, including low emetogenic risk chemotherapy and breakthrough treatment for chemotherapy-induced nausea/vomiting, according to the National Comprehensive Cancer Network 1
Prochlorperazine is also effective for cyclic vomiting syndrome (CVS) 4

Common adverse effects include CNS depression, anticholinergic effects, extrapyramidal symptoms, and rare cases of drug-induced leukopenia or neutropenia, and neuroleptic malignant syndrome 4
Patients should be monitored for hypotension, extrapyramidal symptoms, and akathisia when taking prochlorperazine, although the strength of evidence for this is not provided 2

Monitor for dystonic reactions and use diphenhydramine 25-50 mg PO or IV every 4-6 hours for treatment, as recommended by the National Comprehensive Cancer Network 1
If allergic to diphenhydramine, use benztropine 1-2 mg IV or IM for one dose, followed by oral dose of 1-2 mg daily or BID if needed, as recommended by the National Comprehensive Cancer Network 1
Peripheral IV administration can cause tissue injury, including gangrene or thrombophlebitis 4
Use with caution in patients with a history of leukopenia or neutropenia, dementia, glaucoma, or seizure disorder 4

Prochlorperazine can interact with dofetilide and should be avoided in combination, according to the American College of Cardiology 6
May cause QT prolongation when used with other QT-prolonging medications, according to the American College of Cardiology 6
The American Academy of Family Physicians and the American College of Physicians recommend prochlorperazine for prophylactic antiemetic therapy before chemotherapy with low emetogenic potential, with a standard dosing of 10 mg orally every 6 hours as needed 2, 3, 5